Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-12-017747)

Filing Details

Accession Number:: 0001181431-12-017747
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2012-03-15 17:27:07
Reporting Period:: 2012-03-05

Filing Date:: 2012-03-15
Accepted Time:: 2012-03-15 17:27:07
Original Submission Date:: 2012-03-07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1484478	Furiex Pharmaceuticals Inc.	FURX	Pharmaceutical Preparations (2834)	271197863

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1033409	N Fredric Eshelman	C/O Furiex Pharmaceuticals, Inc. 3900 Paramount Parkway, Suite 150 Morrisville NC 27560		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-03-07	75,000	$21.75	2,135,626	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The purchase of these shares was inadvertently omitted from the Reporting Person's Form 4 filed on March 7, 2012, which affects the amount of shares reported in Table 1, Column 5 of the Reporting Person's subsequent Form 4 filed on March 12, 2012.
Represents the amount of securities that the Reporting Person directly owns as of the filing date of this amendment to Form 4.